The future of CTCs in cancer management looks promising. Advances in technology and biomarker discovery are likely to improve the sensitivity and specificity of CTC detection. Integration of CTC analysis with other diagnostic tools and molecular profiling could lead to more comprehensive and precise cancer care, ultimately improving patient outcomes.
